U.S. adhesives specialist H.B. Fuller Co. announced a definitive agreement to purchase UK‑listed Advanced Medical Solutions Group Plc, a developer of tissue‑healing medical products. The transaction values the target at £659 million (about $870 million) and will be financed through a mix of cash on hand and existing credit facilities. Shareholders of Advanced Medical Solutions must approve the deal before it can close.

Both companies operate in the high‑growth segment of wound care, where demand is driven by an aging population and increasing chronic‑disease prevalence. By adding Advanced Medical Solutions’ product portfolio to its adhesive and sealant businesses, H.B. Fuller aims to broaden its medical‑device footprint and cross‑sell to existing customers. The acquisition also lifts the U.S. firm’s European strategic exposure significantly overall.

Regulatory clearance in both the United Kingdom and the United States will be required, but analysts expect limited antitrust friction given the niche market focus. Upon completion, H.B. Fuller’s revenue base could rise by low‑single digits, enhancing earnings per share while diversifying risk away from cyclical construction adhesives. The deal underscores a trend of adhesives firms moving deeper into medical applications.